Latest filing published 30 Sept 2014 for Cross Country Healthcare INC, €50k.
Insider track record
No signal scores available.
Closed purchases
Based on 2 purchases whose 90-day window has closed (published at least 91 days ago), the same population our ranking model reads.
Purchases by company
Since each purchase
- +18.1%Entry US$4.37 · Close at T+365 US$5.16
Entry is the close on the day after publication, the first price a reader could act on. Prices in the listing currency. Past moves are not a forecast.
Emil Hensel: trading record in brief
Emil Hensel discloses dealings in Cross Country Healthcare Inc to SEC (Form 4). Between 1 November 2006 and 26 September 2014, the trades on record add up to 76 filings.
Both buying and selling appear: 2 purchases worth €38k, against 19 sales worth €1.5M. Netting one side against the other leaves €1.4M of net selling. Unlike grants, an open-market purchase is paid for by the insider, at the market price. The rest of the record consists of 22 share grants and 21 option exercises. In 2014 alone, the filings show no purchases and 9 sales.
On 30 September 2014 came the latest disclosure, an open-market sale for €50k in Cross Country Healthcare Inc. The latest purchase dates back some time: it was published 5,280 days ago, on 25 May 2012. Between a trade and the moment it shows up on SEC (Form 4), the median delay is 2 days. US insiders must file a Form 4 within two business days of a trade. Keep in mind that insiders sell for many reasons unrelated to the outlook, from tax bills to estate planning. These figures are compiled from regulatory filings published by SEC (Form 4). They describe what insiders did and are not a recommendation.
Companies and markets linked to Emil Hensel
Open company profiles for insider transactions, fundamentals and analyst consensus when available.
- 7,000 shares@ US$9.11Common StockSEC:0001012975-14-000638:0
- 5,000 shares@ US$8.92Common StockSEC:0001012975-14-000561:0
- 5,000 shares@ US$8.49Common StockSEC:0001012975-14-000550:0
- 2,167 shares@ US$4.35Common StockSEC:0001012975-14-000513:0
- 5,000 shares@ US$7.98Common StockSEC:0001012975-14-000513:1
- 38,125 shares0Common Stock (restricted)SEC:0001012975-14-000511:0
- 3,000 shares@ US$6.98Common StockSEC:0001012975-14-000494:0
- 3,000 shares@ US$7.27Common StockSEC:0001012975-14-000494:1
- 3,310 shares@ US$7.40Common StockSEC:0001012975-14-000494:2
- 38,125 shares0Common Stock (restricted)SEC:0001012975-14-000382:0
- 1,590 shares@ US$4.35Common StockSEC:0001012975-14-000382:1
- 3,000 shares@ US$6.75Common StockSEC:0001012975-14-000382:2
- 6,930 shares@ US$5.77Common Stock (restricted)SEC:0001012975-14-000347:0
- 22,500 shares0Common StockSEC:0001012975-13-000219:0
- 8,579 shares@ US$5.21Common StockSEC:0001012975-13-000219:1
- 30,000 shares0Common StockSEC:0001012975-12-000173:0
- 6,395 shares@ US$4.35Common StockSEC:0001012975-12-000173:1
- 8,000 shares@ US$3.95Common StockSEC:0001181431-12-032947:0Canonical exit: 21 Aug 2012 (T+90)
- 4,000 shares@ US$4.02Common StockSEC:0001181431-12-032947:1Canonical exit: 23 Aug 2012 (T+90)
- 859 shares@ US$4.47Common StockSEC:0001012975-12-000133:0
- 727 shares@ US$4.18Common StockSEC:0001012975-11-000278:0
- 25,000 shares0Common StockSEC:0001012975-11-000168:0
- 4,742 shares@ US$7.44Common StockSEC:0001012975-11-000168:1
- 859 shares@ US$7.43Common StockSEC:0001012975-11-000110:0
- 2,749 shares0Common StockSEC:0001012975-10-000330:0
25 of 73 declarations
